In 2017, Erbelding became director of the NIAID Division of Microbiology and Infectious Diseases (DMID). She is responsible for the strategic and scientific vision for DMID's complex national and international research program. DMID supports basic, preclinical, and clinical investigations into the causes, diagnosis, treatment, and prevention of a broad range of pathogens, including those related to biodefense and emerging infectious diseases.[1][2]